Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: A systematic review

Alfonso Iorio, Clive Kearon, Esmeralda Filippucci, Maura Marcucci, Ana Macura, Vittorio Pengo, Sergio Siragusa, Gualtiero Palareti

Research output: Contribution to journalArticle

189 Citations (Scopus)

Abstract

Background: We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE) provoked by different transient risk factors. Data Sources: MEDLINE, EMBASE, and Cochrane Collaboration Registry of Randomized Trials databases were searched. Study Selection: Prospective cohort studies and randomized trials of patients with a first episode of symptomatic VTE provoked by a transient risk factor and treated for at least 3 months were identified. Data Extraction: Number of patients and recurrent VTE during the 0- to 12-month and 0- to 24-month intervals after stopping therapy, study design, and provoking risk factor characteristics were extracted. Data Synthesis: Annualized recurrence rates were calculated and pooled across studies. At 24 months, the rate of recurrence was 3.3% per patient-year (11 studies, 2268 patients) for all patients with a transient risk factor, 0.7% per patient-year (3 studies, 248 patients) in the subgroup with a surgical factor, and 4.2% per patient-year (3 studies, 509 patients) in the subgroup with a nonsurgical factor. In the same studies, the rate of recurrence after unprovoked VTEwas 7.4% per patient-year. The rate ratio for a nonsurgical compared with a surgical factor was 3.0 and for unprovoked thrombosis compared with a nonsurgical factor was 1.8 at 24 months. Conclusions: The risk of recurrence is low if VTE is provoked by surgery, intermediate if provoked by a nonsurgical risk factor, and high if unprovoked. These risks affect whether patients with VTE should undergo short-term vs indefinite treatment.

Original languageEnglish
Pages (from-to)1710-1716
Number of pages7
JournalArchives of Internal Medicine
Volume170
Issue number19
DOIs
Publication statusPublished - Oct 25 2010

Fingerprint

Venous Thromboembolism
Recurrence
Information Storage and Retrieval
MEDLINE
Registries
Thrombosis
Cohort Studies
Databases
Prospective Studies

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor : A systematic review. / Iorio, Alfonso; Kearon, Clive; Filippucci, Esmeralda; Marcucci, Maura; Macura, Ana; Pengo, Vittorio; Siragusa, Sergio; Palareti, Gualtiero.

In: Archives of Internal Medicine, Vol. 170, No. 19, 25.10.2010, p. 1710-1716.

Research output: Contribution to journalArticle

Iorio, Alfonso ; Kearon, Clive ; Filippucci, Esmeralda ; Marcucci, Maura ; Macura, Ana ; Pengo, Vittorio ; Siragusa, Sergio ; Palareti, Gualtiero. / Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor : A systematic review. In: Archives of Internal Medicine. 2010 ; Vol. 170, No. 19. pp. 1710-1716.
@article{988a080a8c3145d1b4d80c75f1bebb5e,
title = "Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: A systematic review",
abstract = "Background: We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE) provoked by different transient risk factors. Data Sources: MEDLINE, EMBASE, and Cochrane Collaboration Registry of Randomized Trials databases were searched. Study Selection: Prospective cohort studies and randomized trials of patients with a first episode of symptomatic VTE provoked by a transient risk factor and treated for at least 3 months were identified. Data Extraction: Number of patients and recurrent VTE during the 0- to 12-month and 0- to 24-month intervals after stopping therapy, study design, and provoking risk factor characteristics were extracted. Data Synthesis: Annualized recurrence rates were calculated and pooled across studies. At 24 months, the rate of recurrence was 3.3{\%} per patient-year (11 studies, 2268 patients) for all patients with a transient risk factor, 0.7{\%} per patient-year (3 studies, 248 patients) in the subgroup with a surgical factor, and 4.2{\%} per patient-year (3 studies, 509 patients) in the subgroup with a nonsurgical factor. In the same studies, the rate of recurrence after unprovoked VTEwas 7.4{\%} per patient-year. The rate ratio for a nonsurgical compared with a surgical factor was 3.0 and for unprovoked thrombosis compared with a nonsurgical factor was 1.8 at 24 months. Conclusions: The risk of recurrence is low if VTE is provoked by surgery, intermediate if provoked by a nonsurgical risk factor, and high if unprovoked. These risks affect whether patients with VTE should undergo short-term vs indefinite treatment.",
author = "Alfonso Iorio and Clive Kearon and Esmeralda Filippucci and Maura Marcucci and Ana Macura and Vittorio Pengo and Sergio Siragusa and Gualtiero Palareti",
year = "2010",
month = "10",
day = "25",
doi = "10.1001/archinternmed.2010.367",
language = "English",
volume = "170",
pages = "1710--1716",
journal = "Archives of Internal Medicine",
issn = "0003-9926",
publisher = "American Medical Association",
number = "19",

}

TY - JOUR

T1 - Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor

T2 - A systematic review

AU - Iorio, Alfonso

AU - Kearon, Clive

AU - Filippucci, Esmeralda

AU - Marcucci, Maura

AU - Macura, Ana

AU - Pengo, Vittorio

AU - Siragusa, Sergio

AU - Palareti, Gualtiero

PY - 2010/10/25

Y1 - 2010/10/25

N2 - Background: We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE) provoked by different transient risk factors. Data Sources: MEDLINE, EMBASE, and Cochrane Collaboration Registry of Randomized Trials databases were searched. Study Selection: Prospective cohort studies and randomized trials of patients with a first episode of symptomatic VTE provoked by a transient risk factor and treated for at least 3 months were identified. Data Extraction: Number of patients and recurrent VTE during the 0- to 12-month and 0- to 24-month intervals after stopping therapy, study design, and provoking risk factor characteristics were extracted. Data Synthesis: Annualized recurrence rates were calculated and pooled across studies. At 24 months, the rate of recurrence was 3.3% per patient-year (11 studies, 2268 patients) for all patients with a transient risk factor, 0.7% per patient-year (3 studies, 248 patients) in the subgroup with a surgical factor, and 4.2% per patient-year (3 studies, 509 patients) in the subgroup with a nonsurgical factor. In the same studies, the rate of recurrence after unprovoked VTEwas 7.4% per patient-year. The rate ratio for a nonsurgical compared with a surgical factor was 3.0 and for unprovoked thrombosis compared with a nonsurgical factor was 1.8 at 24 months. Conclusions: The risk of recurrence is low if VTE is provoked by surgery, intermediate if provoked by a nonsurgical risk factor, and high if unprovoked. These risks affect whether patients with VTE should undergo short-term vs indefinite treatment.

AB - Background: We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE) provoked by different transient risk factors. Data Sources: MEDLINE, EMBASE, and Cochrane Collaboration Registry of Randomized Trials databases were searched. Study Selection: Prospective cohort studies and randomized trials of patients with a first episode of symptomatic VTE provoked by a transient risk factor and treated for at least 3 months were identified. Data Extraction: Number of patients and recurrent VTE during the 0- to 12-month and 0- to 24-month intervals after stopping therapy, study design, and provoking risk factor characteristics were extracted. Data Synthesis: Annualized recurrence rates were calculated and pooled across studies. At 24 months, the rate of recurrence was 3.3% per patient-year (11 studies, 2268 patients) for all patients with a transient risk factor, 0.7% per patient-year (3 studies, 248 patients) in the subgroup with a surgical factor, and 4.2% per patient-year (3 studies, 509 patients) in the subgroup with a nonsurgical factor. In the same studies, the rate of recurrence after unprovoked VTEwas 7.4% per patient-year. The rate ratio for a nonsurgical compared with a surgical factor was 3.0 and for unprovoked thrombosis compared with a nonsurgical factor was 1.8 at 24 months. Conclusions: The risk of recurrence is low if VTE is provoked by surgery, intermediate if provoked by a nonsurgical risk factor, and high if unprovoked. These risks affect whether patients with VTE should undergo short-term vs indefinite treatment.

UR - http://www.scopus.com/inward/record.url?scp=78049252755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049252755&partnerID=8YFLogxK

U2 - 10.1001/archinternmed.2010.367

DO - 10.1001/archinternmed.2010.367

M3 - Article

C2 - 20975016

AN - SCOPUS:78049252755

VL - 170

SP - 1710

EP - 1716

JO - Archives of Internal Medicine

JF - Archives of Internal Medicine

SN - 0003-9926

IS - 19

ER -